Lixte Biotechnology

(NASDAQ) LIXT

Current Price$6.21

Market Cap$107.62M

Since IPO (2007)-86%

5 Year-79%

1 Year+373%

1 Month+24%

Lixte Biotechnology Financials at a Glance

Market Cap

$107.62M

Revenue (TTM)

$0.00

Net Income (TTM)

-$7.27M

EPS (TTM)

-$1.12

P/E Ratio

-5.51

Dividend

$0.00

Beta (Volatility)

0.79 (Low)

Dividend

$0.00

Beta (Volatility)

0.79 (Low)

Price

$6.21

Volume

871,823

Open

$7.11

Price

$6.21

Volume

871,823

Open

$7.11

Previous Close

$6.19

Daily Range

$5.88 - $7.11

52-Week Range

$0.64 - $7.51

Estimated Earnings Date

May 14, 2026

Dividend

$0.00

Beta (Volatility)

0.79 (Low)

Price

$6.21

Volume

871,823

Open

$7.11

Previous Close

$6.19

Daily Range

$5.88 - $7.11

52-Week Range

$0.64 - $7.51

Estimated Earnings Date

May 14, 2026

LIXT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lixte Biotechnology

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Geordan G. Pursglove

Website

www.lixte.com

Headquarters

Pasadena, CA 91101, US

LIXT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-159%

Return on Capital

-66%

Return on Assets

-67%

Earnings Yield

-18.15%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$107.62M

Shares Outstanding

17.39M

Volume

871.82K

Avg. Volume

114.46K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$5.11M

EBITDA

-$6.00M

Operating Cash Flow

-$3.07M

Capital Expenditure

$0.00

Free Cash Flow

-$3.07M

Cash & ST Invst.

$5.11M

Total Debt

$664.49K

Lixte Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$107.62M

N/A

Market Cap/Employee

$53.81M

N/A

Employees

N/A

Net Income

-$1.92M

-171.1%

EBITDA

-$1.99M

-382332.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$3.25M

+134.8%

Total Debt

$1.06M

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$461.77K

N/A

Short Term Debt

$595.42K

N/A

Return on Assets

-66.95%

N/A

Return on Invested Capital

-66.26%

N/A

Free Cash Flow

-$1.86M

-226.5%

Operating Cash Flow

-$1.83M

-222.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CINGCingulate Inc.

CINGCingulate Inc.$4.88-4.13%

ALLRAllarity Therapeutics, Inc.

ALLRAllarity Therapeutics, Inc.$1.43-7.74%

ENTOEntero Therapeutics, Inc.

ENTOEntero Therapeutics, Inc.$2.85-5.00%

BCTXBriaCell Therapeutics Corp.

BCTXBriaCell Therapeutics Corp.$2.77+1.09%

PULMPulmatrix, Inc.

PULMPulmatrix, Inc.$1.40+0.36%

CASICASI Pharmaceuticals, Inc.

CASICASI Pharmaceuticals, Inc.$0.15+3.08%

CLSDClearside Biomedical, Inc.

CLSDClearside Biomedical, Inc.$0.41+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

Questions About LIXT

What is the current price of Lixte Biotechnology?

Lixte Biotechnology is trading at $6.19 per share.

What is the 52-week range for Lixte Biotechnology?

Over the past 52 weeks, Lixte Biotechnology has traded between $0.64 and $7.51.

How much debt does Lixte Biotechnology have?

As of the most recent reporting period, Lixte Biotechnology reported total debt of $1.06M.

How much cash does Lixte Biotechnology have on hand?

Lixte Biotechnology reported $3.25M in cash and cash equivalents in its most recent financial results.

What is Lixte Biotechnology’s dividend yield?

Lixte Biotechnology does not currently have a dividend yield.

Lixte Biotechnology

Lixte Biotechnology Financials at a Glance

LIXT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Lixte Biotechnology

LIXT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Lixte Biotechnology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LIXT

What is the current price of Lixte Biotechnology?

What is the 52-week range for Lixte Biotechnology?

How much debt does Lixte Biotechnology have?

How much cash does Lixte Biotechnology have on hand?

What is Lixte Biotechnology’s dividend yield?

Premium Investing Services